Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma-Reference-Cited by-同舟云学术

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma

Published:2020-01 Issue:1 Volume:31 Page:144-152
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ugurel S.,Schadendorf D.,Horny K.,Sucker A.,Schramm S.,Utikal J.,Pföhler C.,Herbst R.,Schilling B.,Blank C.,Becker J.C.,Paschen A.,Zimmer L.,Livingstone E.,Horn P.A.,Rebmann V.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference32 articles.

1. Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017;Ugurel;Eur J Cancer,2017

2. Melanoma;Schadendorf;Lancet,2018

3. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

4. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

5. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy;Topalian;Nat Rev Cancer,2016

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein isoform-centric therapeutics: expanding targets and increasing specificity;Nature Reviews Drug Discovery;2024-09-04

2. Machine learning in the prediction of immunotherapy response and prognosis of melanoma: a systematic review and meta-analysis;Frontiers in Immunology;2024-05-21

3. Novel ultrasensitive automated kinetic exclusion assay for measurement of plasma levels of soluble PD-L1, the predictive and prognostic biomarker in cancer patients treated with immune checkpoint inhibitors;Heliyon;2024-05

4. Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade;Journal of Clinical Investigation;2024-04-01

5. Dynamic MicroRNA-Expression In Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival;Journal of Cancer Genetics and Biomarkers;2024-03-18